⌘K

Home/Insiders/Baker Kevin Paul

BK

SEC Insider//CIK 0001664512

Baker Kevin Paul

CIK 00016645121 companySOUTH SAN FRANCISCO, CA

Transactions

11

Companies

1

Filings

7

CIK

0001664512

Recent Transactions

11 trades

Award
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2018-02-26+3,500→ 78,184 total
Award
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2018-02-26+20,000→ 20,000 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2018-02-05$18.42/sh−930→ 74,684 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2018-02-01$19.73/sh−18,866→ 75,614 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2017-09-01$34.34/sh−940→ 94,480 total
Award
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2017-02-07+5,625→ 88,389 total
Award
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2017-02-07+25,000→ 25,000 total
Award
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2017-02-07+7,031→ 95,420 total
Award
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2016-08-25+7,500→ 82,500 total
Award
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2016-02-01+75,000→ 75,000 total
Award
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2016-02-01+75,000→ 75,000 total

Companies

1

FIVE PRIME THERAPEUTICS, INC.
SVP, Development Sciences

Recent Filings

7

Address

C/O FIVE PRIME THERAPEUTICS, INC. TWO CORPORATE DRIVE

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov